Visit AmoyDx at the 19th World Conference on Lung Cancer (WCLC) 2018 in Canada
Date:2018-09-21Source: AmoyDx
Important Leads:
◎ AmoyDx Essential NGS Panel: Focused on 10 oncogenes approved by FDA for targeted drugs.
◎ Super-ARMS EGFR: Significant improvement on qPCR platform of liquid biopsy EGFR testing.
Recommend
AmoyDx® PD-L1 (E1L3N) assay gained the priority recommendation from Chinese expert consensus
21 /02
AmoyDx has successfully held the 2023 Distributors Annual Meeting at the headquarter in Xiamen, China, on January 22-23, 2024
06 /02
Highlights of China International Import Expo (CIIE) 2023 - Amoy Diagnostics Announced Multiple Collaborations with AstraZeneca and Pfizer
13 /11
AmoyDx® Microsatellite Instability (MSI) Detection Kit Received NMPA Approval for Pan-Tumor Immunotherapy Companion Diagnostics
03 /11
AmoyDx Collaborates with AstraZeneca to Develop a HER2 Companion Diagnostic for Lung Cancer in China
15 /08